CUSIP: 29363K105
Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
18,123,130
-
Share change
-
-194,792
-
Total reported value
-
$441,112,975
-
Price per share
-
$24.39
-
Number of holders
-
81
-
Value change
-
+$22,414,153
-
Number of buys
-
52
-
Number of sells
-
33
Quarterly Holders Quick Answers
What is CUSIP 29363K105?
CUSIP 29363K105 identifies ENTL - ENTELLUS MED INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2018
-
Previous quarter:
Q3 2017
Recent filing periods for CUSIP 29363K105:
Institutional Holders of ENTELLUS MED INC - COM (ENTL) as of Q4 2017
As of 31 Dec 2017,
ENTELLUS MED INC - COM (ENTL) was held by
81 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,123,130 shares.
The largest 10 holders included
Essex Woodlands Management, Inc., SV Health Investors, LLC, Kohlberg Kravis Roberts & Co. L.P., Sand Grove Capital Management LLP, ArrowMark Colorado Holdings LLC, BlackRock Inc., First Light Asset Management, LLC, Vanguard Group Inc, Archon Capital Management LLC, and Aisling Capital LLC.
This page lists
81
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.